Patients who may benefit from risk-reducing surgery include those with:

• a potentially high risk of ovarian cancer – these patients should be referred to a familial cancer service for risk assessment, possible genetic testing and management planning (which may include risk-reducing surgery)
• a high risk of ovarian cancer due to a confirmed gene mutation (surgery is recommended for these patients and should include complete removal of the extrauterine component of both the fallopian tubes and ovaries at a time considered appropriate after consultation with their treating clinicians)
• a high risk of ovarian cancer due to confirmed Lynch syndrome (the surgery should include a hysterectomy and bilateral salpingo-oophorectomy at a time considered appropriate after consultation with their treating clinicians)
• other less common mutations as deemed by a familial cancer service.

For patients who are considering risk-reducing surgery, the surgeon should provide:

• a clear description of the risk-reducing surgery technique and clear information about the objective of the procedure
• information about managing menopausal symptoms and other long-term side effects risk-reducing surgery as well as hormone replacement therapy use
• a discussion about psychosocial wellbeing after risk-reducing surgery